St. Teresa Medical is a company focused on treating surgical bleeding. It develops hemostatic dressing using a proprietary technology FibriSEAL comprised of electrospun dextran, human-derived proteins of thrombin, and fibrinogen embedded into the dextran fibers. The company offers SurgiCLOT, a fibrin sealant designed for bone bleeding, utilizing the dextran nanofibers to deliver a bolus of human fibrinogen and thrombin.